Completed PHASE2 INTERVENTIONAL 2-arm NCT06967025

Ischemic Postconditioning in Acute Stroke Patients Receiving Endovascular Thrombectomy

Ischemic Postconditioning in Acute Stroke Patients Receiving Endovascular Thrombectomy: Mechanistic Exploration Through a Randomized Controlled Pilot Trial

Sponsor: Tianjin Huanhu Hospital

Conditions Cytoprotection Ischemic Conditioning Stroke Acute

Interventions Endovascular Thrombectomy Ischemic Postconditioning

Updated 2 times since 2025 Last updated: Dec 7, 2025 Started: Sep 12, 2024 Primary completion: Aug 15, 2025 Completion: Aug 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06967025, this PHASE2 trial focuses on Cytoprotection and Ischemic Conditioning and remains completed. Sponsored by Tianjin Huanhu Hospital, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jun 2025 — Jan 2026 [monthly]

Recruiting PHASE2

First recorded

Sep 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tianjin Huanhu Hospital

Data source: Tianjin Huanhu Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tianjin, China